Accelerating the Future of Cell & Gene Therapy

At CytoNiche, we specialize in simplifying the complex world of CGT, especially mesenchymal stem/stromal cells (MSCs) to drive the success of therapeutic commercialization. Our solutions empower you to scale up production with cost-effective, high-quality cells, so that you can focus on what you do best —— developing transformative therapeutics. By optimizing access and affordability, we accelerate the timeline for bringing groundbreaking products to market.

See What Powers Us >

Events & News

More Events&News >

Mar 23,2026

CHULA ATMP Symposium

March 30, 2026 | Bangkok, Thailand

Mar 12,2026

CytoNiche Receives Top Bioprocessing Honour at ABEA 2026

Cytoniche Honoured with "Emerging Bioprocessing Supplier Award: Downstream Processing" at ABEA 2026

Mar 04,2026

CITCI – Cumbre Internacional de Terapias Celulares e Inmunológicas

3-4 September 2026 | Guadalajara, Mexico